Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial

Key Points

• Colonic FMT delivers a superior clinical response compared to nasogastric administration, enhancing treatment effectiveness.
• The study identified key immunomodulatory bacteria crucial for restoring a healthy microbe balance in the gut.
• Observational analysis revealed that the engraftment of beneficial bacteria drives enhanced clinical outcomes in ulcerative colitis.
• These findings imply potential for developing targeted microbial therapeutics based on FMT's efficacy.

Abstract